-
90481por Tassi, Renata A., Todeschini, Paola, Siegel, Eric R., Calza, Stefano, Cappella, Paolo, Ardighieri, Laura, Cadei, Moris, Bugatti, Mattia, Romani, Chiara, Bandiera, Elisabetta, Zanotti, Laura, Tassone, Laura, Guarino, Donatella, Santonocito, Concetta, Capoluongo, Ettore D., Beltrame, Luca, Erba, Eugenio, Marchini, Sergio, D’Incalci, Maurizio, Donzelli, Carla, Santin, Alessandro D., Pecorelli, Sergio, Sartori, Enrico, Bignotti, Eliana, Odicino, Franco, Ravaggi, Antonella“…Upon FOXM1 knock-down in EOC-CC1 and OSPC2 cells, microarray and RT-qPCR analyses revealed the deregulation of several common and other unique subtype-specific FOXM1 putative targets involved in cell cycle, metastasis, DNA repair and drug response. CONCLUSIONS: FOXM1 is up-regulated in all three major EOCs subtypes, and is a prognostic biomarker and a potential combinatorial therapeutic target in platinum resistant disease, irrespective of tumor histology. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90482por Jiang, Chunlin, Long, Jianting, Liu, Baoxian, Xu, Ming, Wang, Wei, Xie, Xiaoyan, Wang, Xiaolin, Kuang, Ming“…BACKGROUND: miR-500a-3p has been demonstrated to be involved in the development, progression and metastasis in several human cancers. Constitutive activation of JAK/STAT3 signaling pathway has been reported to play an important role in the development and progression of hepatocellular carcinoma (HCC).The purpose of this study was to determine the biological roles and clinical significance of miR-500a-3p in HCC and to identify whether miR-500a-3p has an effect on the activity of JAK/STAT3 signaling in HCC. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90483por Giesler, Jürgen M, Keller, Bettina, Repke, Tim, Leonhart, Rainer, Weis, Joachim, Muckelbauer, Rebecca, Rieckmann, Nina, Müller-Nordhorn, Jacqueline, Lucius-Hoene, Gabriele, Holmberg, Christine“…The study sample consisted of individuals who had been diagnosed with colorectal cancer within the past 3 years or who had metastasis or recurrent disease. Outcome measures included self-efficacy for coping with cancer and patient competence. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90484por Liu, Cui-zhen, Ye, Zhi-hua, Ma, Jie, He, Rong-quan, Liang, Hai-wei, Peng, Zhi-gang, Chen, Gang“…In addition, decreased miR-141-3p levels were detected in the multiple tumor nodes group (P = .004), the metastasis group (P < .001), and the advanced TNM stage group (P = .01), compared to the single tumor nodes group, the nonmetastasis group, and the early TNM stage group. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90485por Büttner, Florian, Winter, Stefan, Rausch, Steffen, Hennenlotter, Jörg, Kruck, Stephan, Stenzl, Arnulf, Scharpf, Marcus, Fend, Falko, Agaimy, Abbas, Hartmann, Arndt, Bedke, Jens, Schwab, Matthias, Schaeffeler, Elke“…This S3(15)-score was validated in 108 metastatic and non-metastatic ccRCC patients and ccRCC-derived metastases including in part several regions from one metastasis. Univariate and multivariate Cox regression stratified by T, N, M, and G were performed with cancer-specific and progression-free survival as primary endpoints. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90486por Liang, Xu, Vacher, Sophie, Boulai, Anais, Bernard, Virginie, Baulande, Sylvain, Bohec, Mylene, Bièche, Ivan, Lerebours, Florence, Callens, Céline“…PIK3CA mutation was independently associated with worse metastasis-free survival (MFS) in IBC since the median MFS for the PIK3CA mutant type was 26.0 months and for the PIK3CA wild type was 101.1 months (p = 0.002). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90487por Huang, Lei, Jansen, Lina, Balavarca, Yesilda, Babaei, Masoud, van der Geest, Lydia, Lemmens, Valery, Van Eycken, Liesbet, De Schutter, Harlinde, Johannesen, Tom B., Primic-Žakelj, Maja, Zadnik, Vesna, Besselink, Marc G., Schrotz-King, Petra, Brenner, Hermann“…This international population-based study aimed to provide tumor-node-metastasis (TNM) stage- and age-specific survival estimates and trends in resected and overall (resected and unresected) PaC in the early twenty-first century. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90488por Gu, Yulu, Shi, Jikang, Qiu, Shuang, Qiao, Yichun, Zhang, Xin, Cheng, Yi, Liu, Yawen“…BACKGROUND: Ataxia telangiectasia mutated (ATM) gene plays a key role in response to DNA lesions and is related to the invasion and metastasis of malignancy. Epidemiological studies have indicated associations between ATM rs1801516 polymorphism and different types of cancer, but their results are inconsistent. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90489por Chen, Qiuyan, Tang, Linquan, Liu, Na, Han, Feng, Guo, Ling, Guo, Shanshan, Wang, Jianwei, Liu, Huai, Ye, Yanfang, Zhang, Lu, Liu, Liting, Wang, Pan, Li, Yingqin, He, Qingmei, Yang, Xiaoqun, Tang, Qingnan, Li, Yang, Liang, YuJing, Sun, XueSong, Xie, Chuanmiao, Mo, Yunxian, Guo, Ying, Sun, Rui, Mo, Haoyuan, Cao, Kajia, Guo, Xiang, Zeng, Musheng, Mai, Haiqiang, Ma, Jun“…After a median follow-up of 44 months, the 3-year progression-free survival (PFS) and distant metastasis-free survival were 70% and 75%, respectively. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90490por Sharp, Adam, Coleman, Ilsa, Yuan, Wei, Sprenger, Cynthia, Dolling, David, Rodrigues, Daniel Nava, Russo, Joshua W., Figueiredo, Ines, Bertan, Claudia, Seed, George, Riisnaes, Ruth, Uo, Takuma, Neeb, Antje, Welti, Jonathan, Morrissey, Colm, Carreira, Suzanne, Luo, Jun, Nelson, Peter S., Balk, Steven P., True, Lawrence D., de Bono, Johann S., Plymate, Stephen R.“…AR-V7 expression was heterogeneous between different metastases from a patient, although AR-V7 expression was similar within a metastasis. Moreover, AR-V7 expression correlated with a unique 59-gene signature in CRPC, including HOXB13, a critical coregulator of AR-V7 function. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90491“…Also, in vivo experiments proved that EPB41L4A-AS2 suppress tumor growth and extrahepatic metastasis (lung) via the miR-301a-5p-FOXL1 axis. CONCLUSIONS: Taken together, this research revealed a concrete mechanism of lncRNA EPB41L4A-AS2 in HCC, which may serve as a potential biomarkers and novel therapeutic targets for further clinical application. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90492por Al-Jumayli, Mohammed, Batool, Amna, Middiniti, Akshay, Saeed, Anwaar, Sun, Weijing, Al-Rajabi, Raed, Baranda, Joaquina, Kumer, Sean, Schmitt, Timothy, Chidharla, Anusha, Kasi, Anup“…In univariate Cox proportional hazards regression analysis, high-risk features like peripancreatic extension (16%) and perineural invasion (26%) were found to be associated with poor OS. Lymph node metastasis (29%) did not significantly affect OS (HR 1.42, 95% CI [0.73-1.86]; p=0.84). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90493por Taylor, Stuart A, Mallett, Sue, Ball, Simon, Beare, Sandy, Bhatnagar, Gauraang, Bhowmik, Angshu, Boavida, Peter, Bridgewater, John, Clarke, Caroline S, Duggan, Marian, Ellis, Steve, Glynne-Jones, Robert, Goh, Vicky, Groves, Ashley M, Hameeduddin, Ayshea, Janes, Sam M, Johnston, Edward W, Koh, Dow-Mu, Lock, Sara, Miles, Anne, Morris, Stephen, Morton, Alison, Navani, Neal, Oliver, Alfred, O'Shaughnessy, Terry, Padhani, Anwar R, Prezzi, David, Punwani, Shonit, Quinn, Laura, Rafiee, Hameed, Reczko, Krystyna, Rockall, Andrea G, Russell, Peter, Sidhu, Harbir S, Strickland, Nicola, Tarver, Kathryn, Teague, Jonathan, Halligan, Steve“…FINDINGS: Between Feb 26, 2013, and Sept 5, 2016, 976 patients were screened for eligibility. 353 patients were recruited, 187 of whom completed the trial; 52 (28%) had metastasis at baseline. Pathway sensitivity was 50% (95% CI 37–63) for WB-MRI and 54% (41–67) for standard pathways, a difference of 4% (−7 to 15, p=0·73). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90494por Tsai, Cheng-Fang, Chen, Jia-Hong, Wu, Chen-Teng, Chang, Pei-Chun, Wang, Shu-Lin, Yeh, Wei-Lan“…These findings suggest that soluble ICAM-1 produced under leptin treatment is possibly involved in lung and breast cancer bone metastasis.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90495por Abdul Sater, Zahraa, Jha, Abhishek, Hamimi, Ahmed, Mandl, Adel, Hartley, Iris, Gubbi, Sriram, Gonzales, Melissa, Gharib, Ahmed, Pacak, Karel, Cypess, Aaron“…The development of metastasis was similar in both groups (n=10/16, 62.5% vs. n=27/36, 75%; p=0.36). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90496“…And HMGB1 up-regulation was rather prevalent in thyroid cancer tissues and closely correlated with worse overall lymph node metastasis and clinical stage. HMGB1-knockdown dramatically suppressed autophagy, NIS degradation and boosted iodide uptake in HBSS-treated cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90497por Hoffmann, Sabrina H. L., Reck, Dorothea I., Maurer, Andreas, Fehrenbacher, Birgit, Sceneay, Jaclyn E., Poxleitner, Marilena, Öz, Hasan H., Ehrlichmann, Walter, Reischl, Gerald, Fuchs, Kerstin, Schaller, Martin, Hartl, Dominik, Kneilling, Manfred, Möller, Andreas, Pichler, Bernd J., Griessinger, Christoph M.“…With increasing numbers of studies describing MDSC involvement in cancer immune escape, cancer metastasis and the dampening of immunotherapy responses, MDSCs are of high interest in current cancer therapy research. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90498por Barrow, Maya A., Martin, Megan E., Coffey, Alisha, Andrews, Portia L., Jones, Gieira S., Reaves, Denise K., Parker, Joel S., Troester, Melissa A., Fleming, Jodie M.“…CRYβB2 overexpression in triple-negative breast cancers increases invasive cellular behaviors, tumor growth, IL6 production, immune cell chemoattraction, and the expression of metastasis-associated genes. These data underscore that both CRYβB2 and CRYβB2P1 promote tumor growth, but their mechanisms for tumor promotion are likely distinct. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90499por Sledge, George W., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Inoue, Kenichi, Pivot, Xavier, Burdaeva, Olga, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A., Koh, Han, Grischke, Eva-Maria, Conte, PierFranco, Lu, Yi, Barriga, Susana, Hurt, Karla, Frenzel, Martin, Johnston, Stephen, Llombart-Cussac, Antonio“…Randomization was stratified based on site of metastasis (visceral, bone only, or other) and resistance to prior ET (primary vs secondary). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90500por Wei, Li, Wen, Jing-Yun, Chen, Jie, Ma, Xiao-Kun, Wu, Dong-Hao, Chen, Zhan-Hong, Huang, Jiang-Long“…The main causes of poor prognosis in pancreatic cancer include easy metastasis, high recurrence rate, and robust drug resistance. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto